WUXI BIO (02269) announced on September 19 that it will spend 17.5452 million Hong Kong dollars to repurchase 146.8 million shares.

WUXI BIO (02269) announced that on September 19, 2024, the company repurchased 1.468 million shares at a price of 11.72-12.06 Hong Kong dollars per share, with a total expenditure of 17.5452 million Hong Kong dollars. On the same day, in accordance with the Company's Pre-IPO Stock Option Plan adopted on January 5, 2016 (revised on August 10, 2016), 373,800 ordinary shares were issued for the exercise of options.